Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
CellPrint Biotechnology
CellPrint Biotechnology conducts customized studies in drug discovery and diagnostics for partners.
Sector
Subsector
Location
Kryptos Biotechnologies
Kryptos Biotechnologies simplifies biology for clinicians and scientists.
Sector
Subsector
Keywords
Location
total rounds
total raised
ConquerX
ConquerX is a biotechnology company that offers innovative molecular profiling solutions for clinical trials in precision medicine.
Sector
Subsector
Location
total rounds
total raised
AYOXXA
AYOXXA is a biotech company that commercializes innovative technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.07.2024. Their latest round Venture - Series Unknown
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors11
Number of lead investors
Number of investors
ARCH Venture Partners
ARCH Venture Partners is a venture capital firm that specializes in investing in early-stage technology companies in the United States.
Sector
Subsector
Location
count Of Investments
count Of Exists
Keith Crandell
Keith L. Crandell is the Co - Founder & Managing Director, ARCH Venture Partners. He focuses on chemical and specialty materials companies, electronics and instrumentation, optics and photonics, communications, and enterprise infrastructure businesses. He previously served as Senior Manager at ARCH Development Corporation, where he was responsible for ARCH Venture Fund I activities at Argonne National Laboratory. Mr. Crandell has played a key role in the formation and initial funding round of Quanterix, Alfalight, PixelEXX Systems, ALIS Corp. (acquired by Carl Zeiss SMT), Eichrom Industries (acquired by Gary Comer, Inc.), Nanophase Technologies (NANX), and Illinois Superconductor. He was also responsible for ARCH's investment in New Era of Networks (NEON, acquired by Sybase-SY), Apropos Technology (APRS, acquired by Syntellect-ESL), Teach.com (acquired by Intellinex), CelebrateExpress (BDAY, acquired by Liberty Media-LINTA), Ahura Scientific (acquired by Thermo Fisher Scientific-TMO), Adesto Technologies, Ciespace, Boreal Genomics, and Crystal IS (acquired by Asahi Kasei-AHKSY), among others. He is a Director of Quanterix, Nanosys, Alfalight, Adesto Technologies, Boreal Genomics, PixelEXX Systems, Univa, Ciespace. Mr. Crandell also serves as a Director of the Illinois Venture Capital Association. Prior to the founding of ARCH, Mr. Crandell was with the specialty chemical and polymer company, Hercules, Inc. He holds an M.B.A. from The University of Chicago. An M.S. in Chemistry from the University of Texas at Arlington. B.S. in Chemistry and Mathematics from St. Lawrence University.
current job
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Sharon Kedar
current job
Yonghua Capital
Yongyong Investment specializes in equity investment management through its subsidiary Shanghai Chung Hua Investment Management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Peng Yin
Peng is a Professor in the Department of Systems Biology at Harvard Medical School. He also serves as a Core Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he co-founded Ultivue. Co-Founder, Director at Torus Biosystems.
current job
organization founded
Peng Yin
David R. Walt
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300 peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
current job
count Of Investments
David R. Walt
Employee Profiles16
Thomas Huff
Associate director, commercial operations
Louis Levy
Director of corporate and business development at ultivue, inc
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range